Fred Hutchinson Cancer Center

Seattle, WA · Founded 1998

Cancer research and treatment center combining scientific discovery with comprehensive patient care

Primary audience
Business Members
Work area
Regional Advocacy
Topic
Healthcare Policy
Contact
Aaron Crane

About Organization

Fred Hutchinson Cancer Center unites innovative research and compassionate care to prevent, treat, and eliminate cancer and infectious diseases worldwide. Based in Seattle, WA, the organization operates with $1.28 billion in annual revenue and employs 2,549 staff members coordinating 250 volunteers.

What They Focus On

Workforce Development

Supports talent pipeline development through education partnerships and workforce readiness programming initiatives

Economic Growth

Promotes regional economic development through strategic partnerships and support for business expansion initiatives

Business Advocacy

Represents member interests in policy development and advocates for pro-business initiatives at local and state levels

Financial Information

Form 990 data showing organizational financial health and growth.

Revenue (2021)

$1.3B

+36.4% vs 2020

Expenses (2021)

$1.1B

+34.8% vs 2020

Assets (2021)

$3.0B

+95.4% vs 2020

Employees (2021)

2,549

+16.4% vs 2020

Year Revenue Expenses Assets Employees
2021 $1,283,961,922 $1,134,529,429 $2,999,831,201 2,549
2020 $940,996,725 $841,344,866 $1,535,470,671 2,189
2019 $820,892,125 $735,653,659 $1,020,161,042 2,069
2018 $757,282,570 $684,323,509 $753,310,466 1,917
2017 $653,487,789 $610,353,946 $647,980,104 1,811

Source: IRS Form 990 filings. All figures in USD.

How They Work

Learn more
  • 01

    Member Engagement

    Identifies priority issues through stakeholder consultation and analysis of business community needs

  • 02

    Strategic Planning

    Develops targeted initiatives based on member input and regional economic development priorities

  • 03

    Program Implementation

    Executes programs through partnerships with member organizations and community stakeholders

  • 04

    Impact Assessment

    Evaluates outcomes through member feedback and tracks progress toward organizational objectives

Programs and Initiatives

Services and programs offered by Fred Hutchinson Cancer Center

CANCER RESEARCH

Facilitates collaboration and development in cancer research through targeted programming and partnerships

Cancer Research

Supports stakeholders through cancer research programming designed to address community needs

Raise awareness and support research

Facilitates collaboration and development in raise awareness and support research and treatment of childhood cancer. through targeted programming and partnerships

MEDICAL / PUBLIC SERVICES

Provides structured support and resources for medical / public services initiatives across member organizations

YOUNG INVESTIGATOR AWARD

Provides structured support and resources for young investigator award initiatives across member organizations

Team & Leadership

Meet the people behind Fred Hutchinson Cancer Center.

Tom Purcell MD

Tom Purcell MD

Chief Medical Officer
Full-time
Compensation: $608,783
Stephen Graham

Stephen Graham

Director From 04/22
2 hrs/week

Stephen Graham practiced corporate and securities law for several decades as a partner at the major law firms of Perkins Coie LLP, Orrick LLP and Fenwick & West LLP until his retirement from the practice in 2022. Currently, he is chair of the board of directors of Washington Federal Bank, the largest bank headquartered in Washington state with more than $30 billion in assets. He also serves on the national board of Friends of the Children, where he served as chair until the end of 2025. He also serves on the Board of Directors of The Who We Are Project, an organization dedicated to learning about and maintaining awareness of anti-Black racism. In 2019, Graham was appointed to the Securities and Exchange Commission’s Advisory Committee on Small Business Capital Formation and co-chaired the Securities and Exchange Commission’s Advisory Committee on Small and Emerging Companies from 2011 to 2017. He received his JD from Yale Law School.

Thomas Lynch

Thomas Lynch

President & Director
Full-time

Dr. Thomas J. Lynch Jr. is a world-renowned scientist, highly respected oncologist and successful leader of National Cancer Institute-Designated Comprehensive Cancer Centers. As president and director of Fred Hutch and holder of the Raisbeck Endowed Chair, Lynch sets the strategic direction of the center, oversees centerwide initiatives and represents the Hutch’s interests to major partners and governmental bodies. He directs the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium and is principal investigator of its Cancer Center Support Grant. Before becoming Fred Hutch’s sixth president in February 2020, Lynch was most recently chief scientific officer of Bristol Myers Squibb. Previously, he held leadership roles as CEO of Massachusetts General Physicians Organization, director of Yale Cancer Center, physician-in-chief at Yale’s Smilow Cancer Hospital, chief of hematology-oncology at Massachusetts General Hospital and professor of medicine at Harvard Medical Sch

Nancy Davidson MD

Nancy Davidson MD

EVP Clinical Affairs, Dir
Full-time
Compensation: $861,197

Dr. Nancy Davidson is executive vice president and chief academic officer at Fred Hutch, overseeing all faculty affairs and education. She holds the Raisbeck Endowed Chair for Collaborative Research. Davidson, a breast cancer oncologist, has built a worldwide reputation for her expertise and leadership in this field, for her research teasing out the role of hormones in breast cancer growth, and for her impact on the development of new standards of care. She is past president of the American Society of Clinical Oncology and the American Association of Cancer Research. She has been elected to the National Academy of Medicine and the American Academy of Arts and Sciences.

Thomas J. Lynch Jr., MD

Thomas J. Lynch Jr., MD

A world-renowned scientist, highly respected oncologist and successful cancer center leader, Dr. Lynch is motivated by the patients he’s treated to break down silos and free the scientific creativity that will spark new cures. Dr. Lynch holds the Raisbeck Endowed Chair for the Fred Hutch president and director.

Fred Appelbaum, MD

Fred Appelbaum, MD

Bruce Clurman, MD, PhD

Bruce Clurman, MD, PhD

Niki Robinson, PhD

Niki Robinson, PhD

Dr. Robinson is responsible for operations at Fred Hutch including organizational strategy, operational excellence, and the safety and wellbeing of our employees and community. She oversees operational teams that support and accelerate science. These teams include Clinical Operations, Clinical Research Support, Compliance, Data Office, Enterprise Risk, Facilities & Campus Operations, Human Resources, Information Technology, and Research Administration & Clinical Labs. As part of the Fred Hutch Director’s Office, Dr. Robinson also leads Fred Hutch’s strategic planning efforts, working with departments and scientific divisions throughout the organization to ensure that Fred Hutch is positioned to achieve its mission and goals.

Nida Shekhani, MPH

Nida Shekhani, MPH

Nida Shekhani manages the strategy arm of operations at Fred Hutch. This area facilitates the organization’s strategic planning process to identify and establish strategic priorities and goals in order to achieve our mission and uphold our values. In her role, Shekhani oversees the strategic administrative departments and functions of Business Development, Government & Community Relations, Marketing and Communications, and Strategy.

Elizabeth Prescott, PhD

Elizabeth Prescott, PhD

Dr. Prescott, vice president and chief of staff for the Fred Hutch Director’s Office, facilitates information flow and decision-making through collaboration with both administrative and scientific partners throughout Fred Hutch. She also participates in the development of strategies and processes to advance key initiatives.

Ryan Leib, MBA

Ryan Leib, MBA

Denene Prophet-Williams, MBA, MLA, BSN

Denene Prophet-Williams, MBA, MLA, BSN

Garnet Anderson, PhD

Garnet Anderson, PhD

Sue Biggins, PhD

Sue Biggins, PhD

Geoffrey Hill, MD, FRACP, FRCPA

Geoffrey Hill, MD, FRACP, FRCPA

Eric Holland, MD, PhD

Eric Holland, MD, PhD

Sara Hurvitz, MD

Sara Hurvitz, MD

Ramesh Rengan, MD, PhD

Ramesh Rengan, MD, PhD

Nina Salama, PhD

Nina Salama, PhD

Ric Anderson, Chair

Ric Anderson, Chair

Ric Anderson is the cofounder and chief operating officer of Washington Holdings, a real estate company that acquires, develops, manages and invests in assets throughout the western U.S. The company is focused on northwest apartment buildings, west coast hospitality assets, and Silicon Valley research and development business parks. Anderson is a former partner at Lowe Enterprises, a Los Angeles-based real estate investment firm. He received his bachelor’s degree in mechanical engineering from the University of Washington and his master’s degree in business administration from the Anderson School of Management at the University of California, Los Angeles. He has been a long-time board member of Fred Hutch and currently holds board positions at the UW Medicine advisory board, Pacific Real Estate Institute and University Preparatory Academy.

Pete Shimer, Vice Chair

Pete Shimer, Vice Chair

Pete Shimer is the executive committee chair of the Cancer AI Alliance (CAIA), a startup venture among Fred Hutch, other cancer centers and leading technology companies that is developing a platform for improved cancer outcomes, using federated machine learning. Shimer has more than 40 years of executive management experience as well as ownership of enterprise-wide transformation, corporate development, and long-term strategic planning efforts at Deloitte. At Deloitte, he served as the interim Deloitte U.S. chief executive officer, chief operating officer twice, chief financial officer, chair of the U.S. Operating Committee, member and chair of the U.S. Executive Committee, and Seattle managing partner. He led client service relationships for several Fortune 500 companies in the consumer and service industries. Shimer received a BA in Accounting from the University of Washington. He is a member of the Board of Alaska Air Group, a board member for the University of Washington Foster Sch

Julie Nordstrom, Secretary

Julie Nordstrom, Secretary

Julie Nordstrom is a community leader and advocate for health and child development, with extensive experience in board governance and philanthropy. She serves on the Stanford University Department of Health Policy Advisory Board, advising on strategic initiatives to advance health policy innovation and research. She is also a member of the board of the Institute for Health Metrics and Evaluation at the University of Washington and chairs the Head Start Governance Board of Save the Children, which works in six states to provide early childhood development and learning. Previously, Nordstrom was a U.S. trustee of Save the Children, chair of the UW Medicine board and the UW Medical Center board, and founding co-chair of the UW Department of Global Health leadership council. A former practicing attorney at Stafford, Frey, Cooper and Stewart, she earned a law degree from Seattle University School of Law and a bachelor’s degree in political science from the University of Washington. She is

Jim Lico, Treasurer

Jim Lico, Treasurer

Jim Lico retired in June of 2025 from his role as founding president and CEO of Fortive, an industrial technology conglomerate based in Everett, Washington. Lico held his role at Fortive and membership on Fortive's board of directors since the company's founding in 2016. He previously served as the executive vice president and in other leadership positions at life sciences conglomerate Danaher for 20 years. Prior to Danaher, Lico held leadership positions at AlliedSignal and General Motors. He is also a member of the board of directors of Dupont. Jim received a Master’s in Management degree from Northwestern Kellogg School of Management and a Bachelor of Science degree in operations management from the University of Michigan Dearborn.

Sean Boyle

Sean Boyle

Sean Boyle is chief operating officer of Omniva, an AI infrastructure startup. Previously, Boyle served as chief operating officer of Wildlife Studios, a global mobile gaming company; chief financial officer of Amazon Web Services; and chief financial officer of Apptio, a software company based in Bellevue, Washington, that develops technology business-management applications. He also held various financial leadership positions at Ford Motor Company. Boyle earned a bachelor’s degree in commerce and a Master of Business Administration from the University of Windsor. He previously served as treasurer on the board of Rainier Prep, a charter school dedicated to improving educational outcomes for low-income students of color and immigrant students, and as a member of the board of directors for Splunk, where he chaired the audit committee.

Timothy H. Dellit, MD

Timothy H. Dellit, MD

Dr. Timothy Dellit is chief executive officer of UW Medicine, executive vice president for medical affairs, and Paul G. Ramsey Endowed Dean of the School of Medicine at the University of Washington. UW Medicine is an integrated clinical, research and learning health system with a single mission: to improve the health of the public. Its clinically integrated components include the UW School of Medicine; two hospitals, UW Medical Center and Harborview Medical Center; a network of primary care clinics, UW Medicine Primary Care; a large physician practice plan, UW Physicians; and Airlift Northwest, a fixed-wing and helicopter air ambulance service. Previously, Dellit served as chief medical officer for UW Medicine; executive vice dean for clinical affairs and vice president for medical affairs at the University of Washington; and president of UW Physicians. In his leadership roles, Dellit strives to advance UW Medicine's mission to improve the health of the public through providing high-qu

Leigh Morgan

Leigh Morgan

Leigh Morgan is chief executive officer of Imaginal Leadership Strategies, a global advisory firm that works with clients in health care, technology, academia and philanthropy. She previously served as chief strategy and operating officer at Nia Tero; chief operating officer of the Bill & Melinda Gates Foundation; associate chancellor at the UCSF; and vice president and global head of human resources at Genentech. Morgan is the immediate past chair of the Fred Hutch board and serves on the UW Medicine advisory board. She has served as an independent director at Curemark and Kymera Therapeutics and is a member of the Council on Foreign Relations. She also hosts The Space In Between podcast. Morgan earned a master’s degree in organization development from American University, a bachelor’s degree in religion from Duke University and an honorary Doctor of Humane Letters from the Asian University for Women.

Cheryl M. Scott

Cheryl M. Scott

Cheryl M. Scott provides executive and board level counsel on matters of strategy, leadership and governance as the major principal for McClintock Scott. From 1997-2004, she served as the president and CEO of the Seattle-based Group Health Cooperative. Scott’s 8-year tenure as CEO capped a distinguished 25-year career with the organization. Her time at Group Health was followed by 10 years with the Gates Foundation, first as their chief operating officer then followed by several years as their senior advisor in Global Health.

Michelle Seitz

Michelle Seitz

Michelle Seitz, is the founder and CEO of MeydenVest Partners, LLC., a private investment and strategic advisory firm. Prior to founding MeydenVest Partners, she served as chair and CEO of Russell Investments. Before joining Russell, Seitz was CEO of William Blair Investment Management and served on William Blair’s corporate board of directors. With over three decades as both a CEO and investor, Seitz brings deep experience in the financial sector. At the companies she has led, a hallmark of her approach was leveraging her platform and voice to improve peoples’ financial security.

Brad Simmons

Brad Simmons

Brad Simmons is president of UW Medicine Hospitals & Clinics and senior vice president for medical affairs at the University of Washington. Before joining UW Medicine, he worked at UC Davis, first as chief operating officer and later as chief administrator of UC Davis Medical Center and chief operating officer for the hospital division. Simmons previously served as chief operating officer at Saint Luke’s Hospital in Kansas City and senior vice president of medicine, surgical and emergency/trauma services at Parkland Health and Hospital System in Dallas. He earned a master’s degree in health care administration from Washington University School of Medicine and a bachelor’s degree in business administration from Baylor University.

Kathy Surace-Smith

Kathy Surace-Smith

Kathy Surace-Smith has over 35 years of experience advising or working in high-growth private and public companies in both the United States and Europe, including over 20 years of experience in the life sciences industry. From 2013 to 2024, she served as senior vice president and general counsel of NanoString Technologies in Seattle, a provider of spatial biology solutions to the scientific research community, where she managed the company’s legal, human resources and regulatory functions. Previously, she served as vice president and general counsel of SonoSite Inc., an ultrasound technology company based in Bothell, Washington.

Jeff Yurcisin

Jeff Yurcisin

Jeff Yurcisin is the CEO of Grove Collaborative, a leading destination for clean, sustainable, non-toxic products.  His previous leadership includes leading multiple billion-dollar companies and served as a senior executive for 14 years at Amazon. Previously, Yurcisin served as president and CEO of Zulily, an ecommerce company that strives to deliver the best shopping experience for moms nationwide. He also served as CEO of Shopbop, a leading global fashion boutique. While at Amazon, he led the Apparel business and led Amazon’s Private Brands business. He is also on the Board of Governors of the Center for Creative Leadership. Yurcisin earned his bachelor’s degree in economics from Princeton University and graduated with honors from Harvard Business School.

AC

Aaron Crane

Executive Vice President
Full-time
Compensation: $790,366
SH

Steven Huebner

VP, Chief Financial Officer
Full-time
Compensation: $652,598
TM

Theresa McDonnell

SVP, Chief Nursing Officer
Full-time
Compensation: $615,786
KP

Kelly Patrick

VP, Chief Information Officer
Full-time
Compensation: $497,929
SM

Stephanie Mays

VP, Chief Legal Officer
Full-time
Compensation: $436,413
TD

Tami Deeb

VP, Chief Strategy Officer
Full-time
Compensation: $399,220
MD

Moreen Dudley

VP, Chief People Officer
Full-time
Compensation: $317,320
CH

Chad Hoggard

Chief Info Security Officer
Full-time
Compensation: $250,640
BM

Brittany McCreery

VP, Chief Quality & Value Officer
Full-time
Compensation: $231,847
GB

Gansuvd Balgansuren

Director Ci Labs
Full-time
Compensation: $213,773
ME

Maxine Ellis

Director Dei Coaching & Culture
Full-time
Compensation: $200,979
SE

Suni Elgar

Assc Chief Nurse
Full-time
Compensation: $190,332
AW

Alvin Winterroth

Director Thru 03/22
2 hrs/week
BP

Bruce Pym

Director Thru 03/22
2 hrs/week
DB

David Browdy

Vice President & CFO
Full-time
EP

Eduardo Penalver

Director From 04/22
2 hrs/week
GG

Gerald Grinstein

Director Thru 03/22
2 hrs/week
JN

Jeff Nitta

Director Thru 03/22
5 hrs/week
JJ

Jeremy Jaech

Director From 04/22
2 hrs/week
JH

Joanne Harrell

Director From 04/22
2 hrs/week
KB

Kristianne Blake

Director From 04/22
2 hrs/week
LM

Linda Mattox

Director Thru 03/22
1 hrs/week
LB

Lisa Brandenburg

Ex-Officio Director
2 hrs/week
NR

Nicole Robinson

VP & Chief Admin. Officer
Full-time
PR

Paul Ramsey MD

Ex Officio Director 04/22
2 hrs/week
RM

Richard McCune

Director Thru 03/22
3 hrs/week
RW

Russ Williams

Director Thru 03/22
2 hrs/week
RM

Ruth Mahan

Director Thru 03/22
5 hrs/week
SS

Steve Stadum

Director Thru 03/22
1 hrs/week
SB

Suzanne Beitel

Director Thru 03/22
1 hrs/week
AA

Anna Andrews

Interim Proton Ctr Trans Lead
Full-time
Compensation: $306,278
GH

Gretchen Hanna

Dir. Corporate Finance
Full-time
Compensation: $296,607
AM

Ada Mohedano

Dir. Clin. Analytics & Bus Intel
Full-time
Compensation: $258,213
RL

Richard Lafrance

Dir. Pharmacy
Full-time
Compensation: $257,844
SF

Shannon Fernandez

Dir. Finance Ops & Rev Cycle
Full-time
Compensation: $249,324
BJ

Barbara Jagels

VP, Cqv Officer Thru 01/21
Full-time
Compensation: $245,719
NN

Nicki Nguyen-Colvin

Dir. Strategy & Bus Dev
Full-time
Compensation: $242,214
TE

Timothy Ehling

Dir. Nursing & Clin. Ops Integ.
Full-time
Compensation: $239,583
CG

Cindy Gist

VP, Patient Svcs & Clin. Labs
Full-time
Compensation: $238,986
MH

Michelle Hall

Dir. It Operations
Full-time
Compensation: $238,514
DM

Daniel Markus

Dir. Supply Chain
Full-time
Compensation: $236,060
LE

Laura Esagui

Dosimetrist Iii
Full-time
Compensation: $227,006
PH

Paul Helmuth

Dir. Clin Bus Ops, Community Sites
Full-time
Compensation: $223,272
MM

Matthew McSweyn

Dir. Infrastructure & Ops.
Full-time
Compensation: $207,040
CW

Carilla Wallin

Dir. Strat Outreach/Cca Network
Full-time
Compensation: $202,614
SD

Scott Derouen

Dir. Enterprise Proj Mgt.
Full-time
Compensation: $196,821
AJ

Andrew Jackson

Assc Dir Enterprise Apps
Full-time
Compensation: $186,687
TP

Traci Pranzini

Former Key Employee
Full-time
Compensation: $131,743
TW

Tracy Wong

Former Key Employee
Full-time
Compensation: $121,492
CB

Christopher Bundesmann

Corporate Controller
Full-time

Milestones

1998

Organization Founded

1998

Established to serve business community development and economic growth initiatives

2012

Regional Expansion

2012

Extended programming and membership services to serve broader regional business community

2021

Growth Milestone

2021

Achieved significant revenue growth reflecting expanded member services and regional programming

2026

Continued Impact

2026

Maintains active programming serving member organizations and regional economic development priorities

Associated People

Board members, advisors, and key contributors

Board of Directors

HB
Herbert Bone Corporate Treasurer 55.00 hrs/week
JN
Julie Nordstrom Secretary From 04/22 2.00 hrs/week
KG
Karen Glover Imm. Past Chair Thru 03/22 3.00 hrs/week
KS
Kathy Surace-Smith Chair From 04/22 4.00 hrs/week
KM
Kimberly McNally Secretary Thru 03/22 5.00 hrs/week
LM
Leigh Morgan Vice Chair From 04/22 3.00 hrs/week
MD
Mike Delman Treasurer Thru 03/22 2.00 hrs/week
PR
Paula Reynolds Chair Thru 03/22 2.00 hrs/week
SB
Sean Boyle Treasurer From 04/22 2.00 hrs/week
SH
Steven Haydon VP & Gc, Corporate Secretary 55.00 hrs/week
SL
Stewart Landefeld Vice Chair Thru 03/22 2.50 hrs/week
Institutional Review Board
Institutional Review Board Board Member
Conflict of Interest Policies
Conflict of Interest Policies Board Member
SR
Strong Rating by Independent Charity Evaluator Board Member

Information compiled from IRS Form 990 and organizational materials.

Executive Compensation

Top compensated officers & key employees from IRS Form 990

Total Reported (2021)

$7.8M

Highest Paid

$982K

Aaron Crane

Compensated Officers

15

Name Title Base Other Total Hrs/Wk
Aaron Crane Executive Vice President $790,366 $191,393 $981,759 55
Nancy Davidson MD EVP Clinical Affairs, DIR Eff 4/22 $861,197 $43,744 $904,941 37.4
Theresa Mcdonnell SVP, Chief Nursing Officer $615,786 $184,120 $799,906 55
Steven Huebner VP, Chief Financial Officer $652,598 $652,598 55
Tom Purcell MD Chief Medical Officer $608,783 $5,538 $614,321 55
Kelly Patrick VP, Chief Information Officer $497,929 $80,713 $578,642 55
Stephanie Mays VP, Chief Legal Officer $436,413 $98,451 $534,864 55
Tami Deeb VP, Chief Strategy Officer $399,220 $77,557 $476,777 55
Moreen Dudley VP, Chief People Officer $317,320 $54,494 $371,814 55
Gretchen Hanna DIR. Corporate Finance $296,607 $54,932 $351,539 55
Richard Lafrance DIR. Pharmacy $257,844 $65,184 $323,028 55
Chad Hoggard Chief Info Security Officer $250,640 $58,639 $309,279 55
Anna Andrews Interim Proton Ctr Trans Lead $306,278 $306,278 55
Nicki Nguyen-Colvin DIR. Strategy & Bus DEV $242,214 $56,065 $298,279 55
Timothy Ehling DIR. Nursing & Clin. OPS Integ. $239,583 $58,408 $297,991 55

Source: IRS Form 990 filings. Compensation includes base and other reported compensation.

Individual Political Donors

People from this organization who contributed to political campaigns

$4K Total Given
Democratic $3,754 (92%)
Other/PAC $325 (8%)
100 Contributions
$41 Avg Each

Top Individual Donors

18 Individual Donors
ET
Eddie Tatum 4 contributions • $200 avg
$800
JA
Jenny Adams 66 contributions • $9 avg
$572
SA
Steve And Sally Stadum 1 contribution • $500 avg
$500
JC
Jonathan Cooper 1 contribution • $500 avg
$500
JB
Julie Biggerstaff 2 contributions • $150 avg
$300

Other Individual Contributors

#6
RB

Rick Biggerstaff

Spokane, WA

$250 Total
1 Contribution
ACTBLUE
#7
SS

Steve Stadum

Rancho Mirage, CA

$250 Total
1 Contribution
WILL ROLLINS FOR CONGRESS
#8
PP

Patrick Paddison

Seattle, WA

$200 Total
2 Contributions
HARRIS VICTORY
#9
MP

Mikayla Podesta

Bremerton, WA

$200 Total
2 Contributions
ACTBLUE
#10
BJ

Brenda Johnson

Seattle, WA

$178 Total
9 Contributions
ACTBLUE OSBORN FOR SENATE
#11
KC

Karen Carbonneau

Seattle, WA

$100 Total
2 Contributions
MOVEON.ORG POLITICAL ACTION
#12
MG

Monica Gerber

Seattle, WA

$100 Total
2 Contributions
VOTE SAVE AMERICA
#13
EH

Elizabeth Humphries

Gwynn Oak, MD

$47 Total
1 Contribution
HARRIS FOR PRESIDENT
#14
SP

Steven Pergam

Seattle, WA

$25 Total
1 Contribution
FAIR FIGHT
#15
CW

Christine Walenkamp

Seattle, WA

$20 Total
2 Contributions
HARRIS VICTORY
#16
WH

Wendy Hilliker

Seattle, WA

$20 Total
1 Contribution
DNC SERVICES CORP / DEMOCRATIC N...
#17
ER

Erin Renick

Seattle, WA

$10 Total
1 Contribution
HARRIS FOR PRESIDENT
#18
JU

Joe Unger

Seattle, WA

$7 Total
1 Contribution
HARRIS FOR PRESIDENT

Quick Insights

🏆
Most Active Donor Jenny Adams with 66 contributions
💰
Highest Avg per Contribution Eddie Tatum at $200 each
🎯
Top Recipient ACTBLUE — $1,540

Data from Federal Election Commission • Individual contributions only

Partners & Funders

Grant funding relationships from IRS Form 990 filings

$5.6M Grants Received
31 Organizations

Top Funders

31 total
SF
Seattle Foundation 17 grants
$1.2M
MS
Morgan Stanley Global Impact Funding Trust Inc. 4 grants
$756K
SA
Swim Across America Inc
$425K
JG
Jacob Green Charity Classic
$387K
HH
Hyundai Hope on Wheels
$327K
GD
Gs Donor Advised Philanthropy Fund
$276K
MR
Melanoma Research Alliance Foundation
$255K
NC
Natl Christian Charitable Fdn Inc.
$238K
MR
Melanoma Research Foundation
$200K
AS
American Society For Transplantation &
$200K
+21 more funders
Seattle Foundation Morgan Stanley Global Impact Funding Trust Inc. Swim Across America Inc Jacob Green Charity Classic Hyundai Hope on Wheels Gs Donor Advised Philanthropy Fund Melanoma Research Alliance Foundation Natl Christian Charitable Fdn Inc. Melanoma Research Foundation American Society For Transplantation & National Breast Cancer Foundation Inc Brave Like Gabe Foundation Cystic Fibrosis Foundation American Cancer Society Inc. The Fibrolamellar Cancer Foundation Kaiser Foundation Hospitals Conquer Cancer Foundation Of The Cush It To The Limit American Endowment Foundation Mightycause Charitable Foundation Rally Foundation Inc. Yakima Valley Community Foundation American Gift Fund The Ayco Charitable Foundation PAYPAL Charitable Giving Fund Impactassetsinc Community Foundation Of Ncw Northwest Sarcoma Foundation Jewish Community Foundation Of Los Angeles T Rowe Price Program For Charitable
Seattle Foundation Morgan Stanley Global Impact Funding Trust Inc. Swim Across America Inc Jacob Green Charity Classic Hyundai Hope on Wheels Gs Donor Advised Philanthropy Fund Melanoma Research Alliance Foundation Natl Christian Charitable Fdn Inc. Melanoma Research Foundation American Society For Transplantation & National Breast Cancer Foundation Inc Brave Like Gabe Foundation Cystic Fibrosis Foundation American Cancer Society Inc. The Fibrolamellar Cancer Foundation Kaiser Foundation Hospitals Conquer Cancer Foundation Of The Cush It To The Limit American Endowment Foundation Mightycause Charitable Foundation Rally Foundation Inc. Yakima Valley Community Foundation American Gift Fund The Ayco Charitable Foundation PAYPAL Charitable Giving Fund Impactassetsinc Community Foundation Of Ncw Northwest Sarcoma Foundation Jewish Community Foundation Of Los Angeles T Rowe Price Program For Charitable

Source: IRS Form 990 Schedule I filings. Amounts may span multiple tax years.

Federal Funding

Government awards and grants from USAspending.gov

$378.4M Total Obligated
$378.4M Total Amount
100 Awards
2 Agencies

By Agency

HHS $373.4M
USDA $5.0M

Awards (Top 20)

Agency Award ID Type Period Amount
HHS U24CA086368 COOPERATIVE AGREEMENT (B) 2000-2027 $67,679,289
HHS P50CA097186 PROJECT GRANT (B) 2002-2028 $38,742,250
HHS UM1AI069481 COOPERATIVE AGREEMENT (B) 2007-2027 $23,611,215
HHS P50CA228944 PROJECT GRANT (B) 2019-2025 $14,811,581
HHS UH3HL147011 COOPERATIVE AGREEMENT (B) 2020-2026 $9,788,465
HHS C06OD039902 PROJECT GRANT (B) 2025-2028 $7,947,160
HHS U54CA274374 COOPERATIVE AGREEMENT (B) 2022-2027 $7,696,898
HHS R33HL151885 PROJECT GRANT (B) 2020-2026 $7,589,270
HHS U01CA173642 COOPERATIVE AGREEMENT (B) 2013-2025 $7,510,704
HHS R01AI054423 PROJECT GRANT (B) 2003-2027 $7,433,157
HHS R01CA114536 PROJECT GRANT (B) 2005-2026 $7,167,964
HHS R01AR045203 PROJECT GRANT (B) 1998-2026 $7,131,390
HHS R35CA231989 PROJECT GRANT (B) 2018-2026 $6,262,008
HHS U54CA243125 COOPERATIVE AGREEMENT (B) 2019-2025 $6,164,669
HHS R35CA253119 PROJECT GRANT (B) 2021-2028 $5,450,329
HHS U01CA182883 COOPERATIVE AGREEMENT (B) 2013-2025 $5,409,067
HHS R01GM074108 PROJECT GRANT (B) 2005-2025 $5,095,366
HHS P50CA285275 PROJECT GRANT (B) 2024-2029 $5,031,369
HHS U19MD020533 COOPERATIVE AGREEMENT (B) 2024-2029 $5,025,129
USDA 20226701738475 PROJECT GRANT (B) 2022-2026 $4,969,948

+ 80 more awards

Source: USAspending.gov. Amounts represent total federal obligations.

Lobbying Activity

Lobbying Disclosure Act registrations

Self-Lobbying
2 Registrations
2 Clients
Yes Self-Lobbying

Clients 2 total

Fred Hutchinson Cancer Center (Formerly Known As Seattle Cancer Care Alliance)
1 filing
Self
Fred Hutchinson Cancer Center Former "Fred Hutchison Cancer Research Center"
1 filing
Self

Source: Senate Office of Public Records — Lobbying Disclosure Act

Contact

Get in touch with Fred Hutchinson Cancer Center

Visit Website
1100 Fairview Avenue North Seattle, WA 981091024